000			02143 a2200517 4500
005			20250513040547.0
264		0	_c19931208
008			199312s 0 0 eng d
022			_a1042-8194
024	7		_a10.3109/10428199309148553 _2doi
040			_aNLM _beng _cNLM
100	1		_aOkabe, M
245	0	0	_aBCR/ABL oncoprotein-targeted antitumor activity of antisense oligodeoxynucleotides complementary to bcr/abl mRNA and herbimycin A, an antagonist of protein tyrosine kinase: inhibitory effects on in vitro growth of Ph1-positive leukemia cells and BCR/ABL oncoprotein-associated transformed cells. _h[electronic resource]
260			_bLeukemia & lymphoma _cJul 1993
300			_a307-16 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntibiotics, Antineoplastic _xpharmacology
650	0	4	_aBase Sequence
650	0	4	_aBenzoquinones
650	0	4	_aCell Division _xdrug effects
650	0	4	_aDNA, Antisense _xtherapeutic use
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFusion Proteins, bcr-abl _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aLactams, Macrocyclic
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy
650	0	4	_aMolecular Sequence Data
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aPhiladelphia Chromosome
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aQuinones _xpharmacology
650	0	4	_aRNA-Directed DNA Polymerase
650	0	4	_aRifabutin _xanalogs & derivatives
650	0	4	_aTumor Cells, Cultured _xdrug effects
700	1		_aKunieda, Y
700	1		_aMiyagishima, T
700	1		_aKobayashi, M
700	1		_aKurosawa, M
700	1		_aItaya, T
700	1		_aSakurada, K
700	1		_aMiyazaki, T
773	0		_tLeukemia & lymphoma _gvol. 10 _gno. 4-5 _gp. 307-16
856	4	0	_uhttps://doi.org/10.3109/10428199309148553 _zAvailable from publisher's website
999			_c7692525 _d7692525